Barrow Neuro de Phoenix recibe $5M para probar la ibogaína psicodélica en lesiones cerebrales
A $5 million state grant is funding the first U.S. clinical trial of ibogaine for brain injury, which will be conducted in Phoenix. This marks a significant development for research into psychedelic treatments for neurological conditions.
By DMT Code Project · Published August 13, 2026
Sourced from hoodline.com, published August 10, 2026. Cite the original publication, not this page, for the reporting itself.
A $5 million state grant is funding the first U.S. clinical trial of ibogaine for brain injury, which will be conducted in Phoenix. This marks a significant development for research into psychedelic treatments for neurological conditions.